Introduction
Around two-thirds of protein abundance variation of mammalian cells can be accounted for by post-transcriptional mechanisms 1 . Although the role of micro-RNAs (miRNA) in regulating mRNA stability and translation is well-established, an expanding number of proteins that bind AU-rich elements (ARE) in the 3′ untranslated regions (UTR) of mRNA have been discovered to mediate mRNA decay/stabilisation or translational control 2 . Of the dozen or so AU-rich RNA binding proteins (AUBP) that have been characterised in detail 3 , most bind a multimeric pentamer sequence AUUUA, typically located within a 50-150
nucleotide adenine-and uridine-rich 3′ UTR element 3, 4 (and references therein). An estimated 8% of mammalian mRNA transcripts are potentially targeted by AUBPs and many well-characterised AUBP mRNA targets encode key regulatory proteins such as growth factors, cytokines, chemokines and oncoproteins 4 (and references therein). The mechanisms through which AUBPs mediate post-transcriptional regulation, particularly in the context of immune regulation and the inflammatory response, have been reviewed extensively elsewhere [2] [3] [4] [5] [6] [7] [8] . Most function as accessory proteins to recruit mRNAs and to regulate their fate in various sub-cellular compartments, such as the exosome mediating 3′-5′ decay, processing bodies for 5′-3′ decay and stress granules for translational arrest 3, 7 . Some function cooperatively or antagonistically with each other or with argonaut (AGO) endoribonucleases within RNA-induced silencing complexes (RISC) mediating miRNA-dependent decay 7, 8 . In addition, most AUBPs display some degree of molecular promiscuity in their ability to modulate gene expression through ARE-independent mechanisms involving either DNAbinding or protein interaction.
Accumulating data implicates five AUBP types as key regulators of normal and malignant hematopoiesis. These are: ARE poly-U-binding degradation factor-1 (AUF1), HuR (ELAVlike family 1), KH-type splicing regulatory protein (KSRP/KHSRP), nucleolin, and the members of the ZFP36 (Tis11) family, ZFP36, ZFP36L1, ZFP36L2. In this review, we summarise the relevant experimental evidence for this and discuss the complex regulatory interactions that exist between these AUBPs and their mRNA targets and how their functions are integrated with miRNA gene regulatory pathways in hematopoietic cells.
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AUF1
The AUF1 protein occurs in four different isoforms (p37, p40, p42, p45) and regulates gene expression through multiple mechanisms. It directly regulates a number of mRNAs that play key roles in hematopoietic cells including Bcl-2, TNF-α, IL-3, IL-6, COX-2, Cyclin D1, IL-8, c-Fos, c-Jun [9] [10] [11] [12] [13] [14] . It can also modulate mRNA translation and gene transcription. For example, while AUF1 mediates decay of c-Myc proto-oncogene mRNA in cell-free systems 15 , it induces Myc translation in an ARE-dependent manner in K562 erythroleukemia and THP-1 myelomonocytic cell line models 10 . AUF1 associates with the AUBP, nucleolin, to form LR1 promoter and immunoglobulin heavy chain S regions (G-rich regions) involved in class switch recombination 16, 18 . By contrast, AUF1 (p42, and p45 isoforms) exhibits phosphorylation-dependent sequence-specific binding to and transcriptional repression of the CD21 promoter in several B cell lines and in primary B cells 19 .
AUF1 function is essential for normal lymphopoiesis (Fig 1) . Knock-out mice that are deficient in all four AUF1 isoforms display decreased numbers of splenic T and B cells (especially Follicular B cells) together with a modest expansion of the splenic Marginal Zone B cell compartment 20 (Fig 1) . The reduced numbers of Follicular B cells is attributable to increased turn-over and apoptosis, most likely arising as a consequence of decreased levels of pro-survival proteins, Bcl-2, Bcl-Xl and Bfl-1/A1 20 . AUF1-deficient mice also display reduced IgG serum levels in response to T-independent antigen despite no impairment in germinal centre formation and class switch recombination 20 .
AUF1 associates with the Nucleophosmin-Anaplastic Lymphoma Kinase (NMP-ALK) fusion protein that results from the most common translocation, t(2;5)(p23;q35), found in anaplastic large cell lymphoma (ALCL) and some other lymphomas 21 . It co-localises with NMP-ALKcontaining granules where it is targeted for phosphorylation. In its phosphorylated state, AUF1 has been suggested to result in stabilisation of mRNA targets that would otherwise be targeted for decay. The expression of several AUF1 targets such as cyclin A, cyclin D, cMyc 21 and c-Jun 22 correlates with ALCL disease (Table 1) .
HuR/ELAV1
The ubiquitously expressed HuR/ELAV1 member of the ELAV family of AUBP acts to both stabilise and to modulate the translational efficiency of various mRNAs involved in normal and malignant hematopoiesis. It stabilises mRNAs encoding Bcl-2, Mcl-1, Cyclin A, cyclin B1, cyclin D1, lymphotoxin α , GM-CSF, IL-4, VEGF, CD3ζ, CD95L, GATA-3, XIAP, survivin [23] [24] [25] [26] [27] [28] [29] [30] . HuR has also been reported to destabilise mRNAs for AML1/Runx1, CD2, Vav1, NF-κBIE, CD3ε, TNF-α and Stat3
27
. HuR enhances the translational efficiency of mRNAs encoding p53, cytochrome c, XIAP and Bcl-2 while suppressing translation of p27, c-Myc and Wnt5α 26, 29, 31 . The mechanism of HuR-mediated translational repression of c-Myc has been studied in some detail and requires recruitment of let-7 miRNA in an Ago2-dependent manner 32 . Let-7 miRNA functions as translational repressor through recognition of the m 7 G cap on c-Myc mRNA leading to either impaired recruitment of elF4E or to inhibition of elF4E-elF4G association 33 . HuR itself is subject to miRNA-mediated regulation through translational repression by several miRNAs (see Fig 2) including miR-16 and miR-125α 34, 35 , miR-519 36 and miR-34α 37 .
Recent transcriptome-wide screening has identified many thousands of additional mRNAs that are direct and functional targets of HuR in human cells 38, 39 . HuR binding sites that overlap with or are adjacent to miRNA binding sites facilitate combinatorial regulation by HuR and miRNAs, most likely through alleviation of miRNA-mediated repression by HuR 39 .
Significantly, many HuR binding sites occur in introns and are often associated with splice sites to regulate alternative splicing. RNA processing mechanisms also account for HuRmediated repression of the miR-7 miRNA that functions as a potent tumour suppressor in many human cancer types 38 .
HuR is required for normal mouse embryonic development 40 . The postnatal function of HuR was investigated in a tamoxifen-dependent cre recombinase deletion mouse model 40 .
Following tamoxifen-induced HuR deletion, mice die within 10 days. An analysis of the hematopoietic system within the first four days of tamoxifen treatment revealed that these mice are characterized by possession of atrophic spleens, lymph nodes and thymus accompanied by reduced numbers of lymphoid, myeloid and erythroid progenitor cells in the bone marrow 40 (see Fig 1) . The peripheral blood lymphocyte count is markedly diminished while granulocyte numbers are modestly increased; red blood cell and platelet counts are unaffected 40 . . However when deletion of HuR was specifically targeted to thymocytes 27 , there were increased numbers of thymic DN, SP and DP cells in thymus (Fig 1) . In the latter study, HuR was found to affect the proliferation of double negative cells, the process of positive selection and the egress of mature T cells to the periphery 27 . Increased proliferation of the DN cells was attributed to decreased p53 protein levels 27 . Additionally these mice displayed an impaired germinal centre formation and IgG1 secretion in response to a T-cell-dependent antigen 41 .
In common with AUF1, HuR co-localises with NMP-ALK in NMP-ALK granules in ALCL and is a substrate for tyrosine phosphorylation by this kinase 42 . The level of cytoplasmic HuR is not affected by the presence of NMP-ALK which instead promotes its localisation to polysomes and binding to cEBPβ mRNA 42 . This results in stabilisation and increased translation of cEBPβ mRNA 42 . Increased expression of c-EBPβ is a unique feature of ALCL compared with several other leukemias and lymphomas 42 . The c-EBPβ protein regulates apoptosis in ALK-positive cell lines as well as tumour growth in mice in vivo 43 .
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One intriguing mRNA target for HuR in leukemogenesis is the mRNA encoding the prosurvival protein, survivin (Table 1) . Over-expression of HuR results in inhibition of p53-dependent transcription and down-regulation of expression of the survivin protein 23 . HuR stabilises p53 mRNA leading to increased levels of p53 protein which in turn negatively regulates survivin gene transcription. However, when p53 is silenced, HuR over-expression actually increases levels of survivin by stabilising its mRNA. This suggests that the outcome of HuR expression on survivin levels may depend on the p53 mutational status of leukemic cells 23 .
Finally, HuR have been implicated in post-transcriptional genotoxic/oxidative stress pathways in mammalian cells 47 and recent data has shown that it functions as a key mediator of the checkpoint kinase, ATM (ataxia telangiectasia mutated) in B lymphocyte cell lines 48 .
In response to double-stranded DNA breaks, the ATM kinase phosphorylates a cascade of downstream effectors including the checkpoint kinase, Chk2, which in turn phosphorylates
HuR to modulate its mRNA-binding and translational control functions. Ionising radiation elicits a dramatic change in the profile of mRNAs that are associated with HuR in an ATMdependent manner. Of these, the mRNAs encoding cancer-associated proteins p21, FOXO3, MEK1, MEK2, DUSP10 and (interestingly) the AUBP, ZFP36L1 were experimentally validated as ATM-regulated HuR targets. In each case, radiation-responsive up-regulation of their encoded proteins was mediated by translational control rather than by changes in mRNA levels 48 .
Individuals with the autosomal recessive ataxia telangiectasia (AT) condition who inherit defective ATM function are predisposed to develop lymphomas and lymphoid leukemias at high frequency. The ATM gene is also commonly mutated in sporadic lymphoid malignancies. Thus HuR likely plays a key role in mediating the effects of loss of function of promote the association of Drosha with pri-miRNA and of Dicer with pre-miRNA at least for let-7a and miR-21 51 and as thus to promote their maturation. Another report found that KSRP is involved in the maturation of miR-155 from pri-and pre-miR-155 after LPS stimulation in macrophages 52 .
The KSRP protein also targets Id3 inhibition of E2A-regulated transcription of the Notch1 gene 53 . Deregulated Notch1 expression arising either through mutational mechanisms or the t(7;9) translocation has been causally associated with the development of human T-acute lymphoblastic leukemia (T-ALL) 53 . Although one published study has reported high expression of KSRP in CML acute phase/blast crisis compared with chronic phase disease 45 ( Table 1) , it remains to be determined whether altered expression/function of KSRP plays a causal role in leukemogenesis via miRNA maturation or other pathways.
Nucleolin
Nucleolin is found in the nucleolus, nucleoplasm, and the cell membrane 54 and possesses a diverse set of functions such as regulation of PolI-and PolII-mediated transcription, nucleocytoplasmic transport, the formation of nucleosomes and chromatin remodeling, in addition to its role in the stabilization of certain mRNAs through binding to AREs 
57
. Independently of its ability to bind Bcl-2 mRNA, nucleolin can also interact with phosphorylated Bcl-2 protein in the nucleus during the transition from prophase to anaphase in mitosis 58 . This may affect spindle formation as well as chromosome segregation 58 . In hematopoietic cells, nucleolin regulates transcription of the CD34 gene by direct binding to the CD34 promoter 59 , a process that is negatively regulated by hypophosporylated Rb
60
. As mentioned previously, nucleolin, together with AUF1 forms the transcriptional regulatory LR1 complex that regulates multiple genes in lymphocytes 16, 17 . . In response to CD21 activation, it also becomes tyrosine phosphorylated and associates with the unphosphorylated p85 subunit of the PI3K pathway 68 .
Finally, through RNA-dependent association with DGCR8, nucleolin may serve an adaptor function in transferring the pri-miRNAs to the nucleolus and in the processing-cleavage of pri-miRNAs to pre-miRNA within the nucleolus by a Drosha-DGCR8-nucleolin complex 69 .
As summarised in Table 1 72 . Expression of these two proteins positively correlated with higher relapse rates and negatively correlated with overall survival and relapse-free survival 72 (Table 1) .
ZFP36 family
The three ZFP36 family members, ZFP36, ZFP6L1 and ZFP36L2, function primarily by targeting an extensive, overlapping repertoire of mRNAs for degradation via the exosome or via Xrn1 exonuclease 3, 5 . One exception to this is ZFP36 which has recently been shown to also target the NF-κB pathway via ARE-independent mechanisms involving recruitment of HDAC1 or HDAC3 to the NF-κB p65 subunit 73 and through inhibition of p65 nuclear import 74 .
Several studies in cell line models and primary cells have implicated all three members of the Definitive insight into the distinctive role of each ZFP36 family member in hematopoiesis has been provided by gene targeting studies in mice (see Fig 1) . Loss of ZFP36 function results in an increase in the numbers of granulocytes in the spleen and bone marrow accompanied by a decrease in the numbers of B cells in the bone marrow 78 . This is attributable to increased proliferation of short term hematopoietic stem cells and multipotent progenitor cells arising from increased levels of G-CSF, IL-1β, IL-6, TNF-α found in the plasma of ZFP36 knockout mice and these effects are non-cell-autonomous 78 . The defective hematopoiesis may also arise from dysregulation of the transcription factor, E47, the mRNA of which is normally targeted for degradation by ZFP36 79 . The defective hematopoietic phenotype seen in ZFP36L2-deficient mice (Fig 1) is associated with elevated Cxc11 expression and diminished levels of Cxcl4, Cxcl7, integrin a2b (CD41), integrin b3 (CD61), CD59α, SLAMF1, PBX1 80 . Conditional knock-out mice in which loss of ZFP36L1/L2 function is targeted to lymphocytes (Fig 1) display widespread defects in lymphopoiesis.
Notably, all ZFP36L1/L2 double knockout mice developed thymic tumours and the majority also displayed other abnormalities including splenomegaly and lymphadenopathy 81 .
Interestingly, in these same mice, there was a block in B cell development from the CD25+B220+ stage (Fig 1) , although presumably this was not B cell intrinsic as deletion of ZFP36L1/L2 in these mice was under control of CD2-cre and CD2 is not expressed in B cells 82 .
Consistent with their pro-apoptotic functions, members of the ZFP36 family have been implicated as tumour suppressors in solid tumours 83 . A similar functional role for these proteins is emerging in leukemogenesis. Compelling evidence for this is provided by the recent finding that concomitant targeted deletion of ZFP36L1 and ZFP36L2 in mouse thymocytes results in T-ALL as early as 3 months of age while single deletion has no effect 81 .
The CD8+ tumours are oligoclonal in nature, and their development is attributable to deregulated expression of Notch1 mRNA, which is normally targeted for degradation by ZFP36L1 81 . As mentioned previously, deregulated Notch1 expression has been causally associated with the development of human T-ALL 53 .
At a mechanistic level, loss of function of different ZFP36 family members is very likely to contribute to leukemogenesis through multiple mechanisms (Table 1) . In adult T cell lymphoma (ATL), ZFP36 but not ZFP36L1, has been found to physically associate with the Tax protein and to inhibit its transactivation function 84 . The Tax-ZFP36 complex is targeted to the proteasome resulting in increased degradation of Tax 84 . In addition, ZFP36 may recruit HDAC1 and HDAC3 to Tax with concomitant inhibition of p300/CBP recruitment as shown for the p65 NF-κB subunit 73 . Indeed, Tax protein has been found to associate with p300/CBP and HDAC1 or HDAC3; the presence of HDAC1 inhibits the binding of p300/CBP to Tax that is required for Tax transactivation function 85 . The physical association between ZFP36
and Tax also appears to titrate out ZFP36 function since Tax inhibits degradation of TNF-α mRNA by ZFP36 in ATL 84 . A similar mechanism may contribute to the deregulated expression of other cytokines in ATL such as IL-2, IL-6, IL-10, GM-CSF that are induced by HTLV-1 virus and that are targets for ZFP36 84 . Consistent with a role for loss of ZFP36 function in disease progression of ATL, ZFP36 mRNA is down-regulated in acute phase ATL compared with chronic phase disease 86 ( Table 1) .
The transcription factor, NF-κB functions in one of the most frequently deregulated pathways in leukemias and lymphomas 87 , and is a key target for mRNA decay and transcriptional repression by the ZFP36 protein as mentioned previously 73, 74 . ZFP36 together with ZFP36L1 also functions in miRNA pathways in leukemogenesis. mRNA targets for miR-16/miR-15 are enriched in AREs motifs 46 and miR-16 requires the presence of ZFP36 and ZFP36L1 in order to bind to ARE-containing mRNA 88 . miR-16/miR-15 are commonly down-regulated in BCLL and indeed miR-16/miR-15 knockout mice develop BCLL 89 . One intriguing possibility is that in BCLL cases in which miR-16/miR-15 expression is not down-regulated, the absence of ZFP36 family members may promote the development of CLL indirectly by attenuating the function of miR-16/miR-15. ZFP36L1 is expressed at low levels in most BCLLs 75 . In some cases this may be attributable to an interstitial deletion of the ZFP36L1 locus at 14q24 90 . Interestingly, ZFP36L2 mRNA is differentially expressed between BCLL cases with high and low levels of miR-16/miR-15 46 consistent with its mRNA being targeting by miR-16 34 . Other genetic/epigenetic mechanisms are also likely to be involved in downregulating expression of ZFP36 family members. In B cell lymphomas for example, the promoters of the ZFP36 and ZFP36L1 genes are targeted for transcriptional repression by the BCL-6 oncogene 91, 92 .
In myeloid leukemias, the expression of ZFP36 family members is correlated with clinicopathological features of disease (Table 1) . In two independent studies of CML, ZFP36 expression displays a progressive decrease during transit from chronic phase to blast crisis 45, 93 . ZFP36 is known to target Stat5b mRNA for degradation in CD34-positive haematopoietic cells 77 . Since proliferation and survival of BCR-ABL-transformed cells requires Stat5 function 94 , loss of ZFP36 function would be expected to enhance the malignant properties of CML cells. ZFP36L1 by contrast, is reportedly over-expressed in M2 AML carrying the AML1-ETO translocation and this is correlated with induction of cell proliferation and inhibition of differentiation 95 . Similarly, ZFP36L2 mRNA was found to be over-expressed in resistant/relapsed AML patients 96 .
Most established tumour suppressor genes are found in mutant form in at least a sub-set of tumours in which they are involved. Recent data indicates that at least for ZFP36L1 and (Table 1) . High throughput sequencing of primary multiple myeloma (MM) cases has identified deletions within a regulatory intron of the ZFP36L1 gene in a significant minority of cases 97 . Although the functional significance of this remains to be established, the same study also found that the Rrp44 gene (encoding exosome component 11) is mutated within its coding region in 11% of MM patients 97 
Conclusions and Perspectives
Given the multitude of important regulators of cell growth, differentiation and survival that are targeted at the post-transcriptional level by AUBPs, it is perhaps unsurprising that the phenotypes of mice that are deficient in their genes manifest in various defects in hematopoiesis. As discussed previously, multiple AUBPs often function in association within defined sub-cellular compartments and bind concomitantly to the same mRNA 3, 6, 7 . 
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